Rohit Katial

Effects of benralizumab on airway eosinophils in asthmatic patients with sputum eosinophilia

Michel Laviolette, David Gossage, Gail M. Gauvreau et al. · Journal of Allergy and Clinical Immunology · 2013 · 495 citations

Asthma, Allergy, Respiratory Diseases +8

Use and interpretation of diagnostic vaccination in primary immunodeficiency: A working group report of the Basic and Clinical Immunology Interest Section of the American Academy of Allergy, Asthma & Immunology

Jordan S. Orange, Mark Ballow, E. Richard Stiehm et al. · Journal of Allergy and Clinical Immunology · 2012 · 444 citations

Primary Immunodeficiency, Vaccination, Asthma +11

Long-term safety and efficacy of benralizumab in patients with severe, uncontrolled asthma: 1-year results from the BORA phase 3 extension trial

William W. Busse, Eugene R. Bleecker, J Mark FitzGerald et al. · The Lancet Respiratory Medicine · 2018 · 298 citations

Asthma, Rheumatology, Extension Trial +10

Safety profile, pharmacokinetics, and biologic activity of MEDI-563, an anti–IL-5 receptor α antibody, in a phase I study of subjects with mild asthma

William W. Busse, Rohit Katial, David Gossage et al. · Journal of Allergy and Clinical Immunology · 2010 · 276 citations

Asthma, Biologic Activity, Mild Asthma +8

The Aerocrine exhaled nitric oxide monitoring system NIOX is cleared by the US Food and Drug Administration for monitoring therapy in asthma

Philip E. Silkoff, Mats Carlson, Trevor Bourke et al. · Journal of Allergy and Clinical Immunology · 2004 · 162 citations · Full text

Asthma, System Niox, Medicine +5